Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherArticle

Repression of OATP1B Expression and Increase of Plasma Coproporphyrin Level as Evidence for OATP1B Down-regulation in Cynomolgus Monkeys Treated with Chenodeoxycholic Acid

Yueping Zhang, Shen-Jue Chen, Cliff Chen, Xue-Qing Chen, Sagnik Chatterjee, David J. Shuster, Heather Dexter, Laura Armstrong, Elizabeth M. Joshi, Zheng Yang and Hong Shen
Drug Metabolism and Disposition May 30, 2022, DMD-AR-2022-000875; DOI: https://doi.org/10.1124/dmd.122.000875
Yueping Zhang
1Bristol-Myers Squibb, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shen-Jue Chen
2Bristol Myers Squibb, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cliff Chen
2Bristol Myers Squibb, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xue-Qing Chen
2Bristol Myers Squibb, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sagnik Chatterjee
3Bristol Myers Squib, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Shuster
2Bristol Myers Squibb, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Dexter
2Bristol Myers Squibb, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Armstrong
2Bristol Myers Squibb, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth M. Joshi
2Bristol Myers Squibb, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zheng Yang
2Bristol Myers Squibb, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zheng Yang
Hong Shen
4Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Hong.Shen1@bms.com
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Additional Files

  • Data Supplement

    • Supplemental Figures -

      Supplementary Figure 1.   Mean plasma concentrations of LCA (A), CA (B), and DCA (C) before (Day -4 and Day -2),
      during (Day 1 to Day 8), and one day after (Day 9) administration of CDCA (50 and 100 mg/kg/day) in three male cynomolgus monkeys. Data are shown as the mean and SD values.

      Supplementary Figure 2.  Mean plasma concentrations of LCA (A), CA (B), and DCA (C) on Day 1 after the first vehicle
      (blue closed squares), 50 mpk CDCA (red closed triangles), or 100 mpk CDCA dose (black closed circles), and on Day 8 after the eighth vehicle (blue open squares), 50 mpk CDCA (red open triangles), or 100 mpk CDCA dose (black open circles) are shown as mean and SD values.

      Supplementary Figure 3.  Effects of CDCA and RIF treatments on the liver concentrations of CPI (A), CPIII (B), CDCA
      (C), LCA (D), CA (E), and DCA (F) of cynomolgus monkeys.

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 50 (6)
Drug Metabolism and Disposition
Vol. 50, Issue 6
1 Jun 2022
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Repression of OATP1B Expression and Increase of Plasma Coproporphyrin Level as Evidence for OATP1B Down-regulation in Cynomolgus Monkeys Treated with Chenodeoxycholic Acid
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherArticle

OATP1B down-regulation in CDCA treated monkeys

Yueping Zhang, Shen-Jue Chen, Cliff Chen, Xue-Qing Chen, Sagnik Chatterjee, David J. Shuster, Heather Dexter, Laura Armstrong, Elizabeth M. Joshi, Zheng Yang and Hong Shen
Drug Metabolism and Disposition May 30, 2022, DMD-AR-2022-000875; DOI: https://doi.org/10.1124/dmd.122.000875

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherArticle

OATP1B down-regulation in CDCA treated monkeys

Yueping Zhang, Shen-Jue Chen, Cliff Chen, Xue-Qing Chen, Sagnik Chatterjee, David J. Shuster, Heather Dexter, Laura Armstrong, Elizabeth M. Joshi, Zheng Yang and Hong Shen
Drug Metabolism and Disposition May 30, 2022, DMD-AR-2022-000875; DOI: https://doi.org/10.1124/dmd.122.000875
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME properties of abrocitinib
  • Impact of physiological microenvironments on HepaRG cells
  • New Dog, Cat, and Pig P450 2J Enzymes
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics